Practice Guidelines for Outpatient Parenteral Antimicrobial Therapy
Open accessThe DOI matches its Crossref record; 235 of the 239 references it cites were found in a registry or an index.
Abstract
These guidelines were formulated to assist physicians and other health care professionals with various aspects of the administration of outpatient parenteral antimicrobial therapy (OPAT). Although there are many reassuring retrospective studies on the efficacy and safety of OPAT, few prospective studies have been conducted to compare the risks and outcomes for patients who receive treatment as outpatients rather than as inpatients. Because truly evidence-based studies are lacking, the present guidelines are formulated from the collective experience of the committee members and advisors from related organizations. Important aspects of OPAT are described in the text and tables and include the following: The literature supports the effectiveness of OPAT for a wide variety of infections (table 1 and the Appendix). Infections treated with outpatient parenteral antimicrobial therapy (OPAT) and the antibiotics used in 4 studies or sites. A thorough assessment of the patient's general medical condition, the infectious process, and the home situation is necessary before starting therapy (table 2) Specific considerations in evaluating patients for outpatient parenteral antimicrobial therapy (OPAT). Prescribing physicians should be aware of a number of aspects of OPAT which distinguish it from other forms of therapy. These include the required teamwork, communication, monitoring, and outcome measurements (tables 3 and 4). Key elements required for an outpatient parenteral antimicrobial therapy (OPAT) program. Key elements required for evaluating an outpatient parenteral antimicrobial therapy (OPAT) program when the patient is to be referred. The physician has a unique role on the OPAT team, which may also include nursing, pharmacy, and social services. These responsibilities include establishing a diagnosis, prescribing treatment, determining the appropriate site of care, monitoring during therapy, and assuring the overall quality of care. Antimicrobial selection for OPAT is different from that for therapy in the hospital. Once-daily drug administration has many advantages. Potential for adverse effects and the stability of an antimicrobial once it is mixed must be considered (tables 5–7). Properties of commonly prescribed antimicrobials at various temperatures. Suggestions for laboratory parameters that should be monitored weekly during outpatient parenteral antimicrobial therapy (OPAT). The importance of administering the first dose of an antibiotic in a supervised setting is emphasized. Regular clinical and laboratory monitoring of patients receiving OPAT is essential and varies with the antimicrobial chosen (table 8). Outcome measures for outpatient parenteral antimicrobial therapy (OPAT). Outcomes measures should be an integral part of any OPAT program, to assure the effectiveness and quality of care (table 9). Internet resources with information on outpatient parenteral antimicrobial therapy (OPAT). Children receiving OPAT must be considered differently because of their special needs. The practice of administering intravenous antimicrobial therapy in the home and in alternate care settings has grown rapidly since it was first described in 1974 by Rucker and Harrison [1]. The most common infections treated and antimicrobials used by a variety of programs are shown in table 1. In the United States, OPAT is estimated to be a multibillion-dollar-a-year industry and is provided to 1 in 1000 Americans each year [10]. The growth of OPAT has been fueled by a variety of factors including the push for cost containment, the development of antimicrobial agents that can be administered once daily, technological advances in vascular access and infusion devices, increased acceptance of such therapy by both patients and health care personnel, and the availability of reliable and skilled services for OPAT in the community. Although OPAT has become widely accepted as a form of medical therapy (see Appendix), more information is needed regarding its benefits, safety, and limitations. This is especially true with the economic incentives for early discharge that exist for payors. These guidelines update those written in 1997 [11] and are intended to ensure successful implementation of parenteral antimicrobial services for patients in varied community settings, including the home and outpatient facilities, such as physicians' offices, hospital clinics, ambulatory-care centers, day hospitals, and skilled nursing facilities. They have been formulated to incorporate the perspectives of the team of physicians, nurses, pharmacists and other health care professionals necessary for an effective and safe program [6, 8, 12]. Advice and participation were requested of the leading infusion-nurse, pharmacy, and to a on the The were formulated from the collective clinical experience of the of and from the organizations. In the of the and quality of in of OPAT is by a of prospective studies and a number of are The information can a for programs to
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Outpatient parenteral antibiotic therapy (OPAT) is efficacious, safe, and cost-effective for a variety of infections, [323][324][325] including IE that requires prolonged parenteral therapy in hospitalized patients who otherwise no longer require inpatient care but do require continued parenteral antimicrobial therapy.”
Citations
Cites
Guidelines for the Prevention of Intravascular Catheter-related Infections
O'Grady, N. P., Alexander, M., Burns, L. A., Dellinger, E. P., Garland, J., Heard, S. O., Lipsett, P. A., Masur, H., Mermel, L. A., Pearson, M. L., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir257 · Cited by 4,699
Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010.
Schrag, S. D., Gorwitz, R. J., Fultz-Butts, K., & Schuchat, A. (2002) · PubMed · Cited by 3,349
Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults
Bartlett, J. G., Dowell, S. F., Mandell, L. A., File, T. M., Musher, D. M., & Fine, M. J. (2000) · Clinical Infectious Diseases · doi:10.1086/313954 · Cited by 2,286
Medication Errors and Adverse Drug Events in Pediatric Inpatients
Kaushal, R. (2001) · JAMA · doi:10.1001/jama.285.16.2114 · Cited by 1,917
Guidelines for the management of intravascular catheter-related infections
Mermel, L. A., Farr, B. M., Sherertz, R. J., Raad, I. I., O'Grady, N., Harris, J. S., & Craven, D. E. (2001) · Clinical Infectious Diseases · doi:10.1086/320001 · Cited by 1,449
Guidelines for the prevention of intravascular catheter-related infections
da Silva, G. D., de Almeida, V. S., Querido, D. L., Esteves, A. P. V. D. S., dos Santos, J. P. O., & Rezende, T. F. (2012) · doi:10.5205/3705 · Cited by 1,119
Niederman, M. S., Bass, J. B., Campbell, G. D., Fein, A. M., Grossman, R. F., Mandell, L. A., Marrie, T. J., Sarosi, G. A., Torres, A., & Yu, V. L. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/148.5.1418 · Cited by 1,045
(2001) · PsycEXTRA Dataset · doi:10.1037/e548252006-001 · Cited by 1,018
Quality of Care, Process, and Outcomes in Elderly Patients With Pneumonia
Meehan, T. P. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550230056037 · Cited by 919
Research works printed but not linked: 28
- Winters, 1992, Home infusion therapy: a service and demographic profile: a report for the National Alliance for Infusion Therapy, 1
- Hankwitz, 1994, The expanding and increasingly important role of the home health care agency medical director, Am Ac Home Care Phys Newsletter, 6, 8
- Tice, 1993, Growing pains in outpatient intravenous antibiotic therapy, Infect Dis Clin Pract, 1, 74
- 1986, Wickline v State of California, 228 Cal. Rptr. 661, 192. Cap. App. 3d 1630
- 1981, Physicians, surgeons and other healers. American Jurisprudence, 226
- Tice, 1997, Delivery models for outpatient parenteral antimicrobial therapy. In: Outpatient parenteral antimicrobial therapy: current status, 7
- Residency Review Committee, Specific program content. CAAR Program Information from Workshop for Internal Medicine Subspecialty Residencies in Infectious Disease. 11. 2001. American Board of Internal Medicine. Ref Type: Conference Proceeding.
- Lonsway, 2001, Intravenous therapy in the home, 501
- Mortlock, 2001, Intravenous therapy in the alternative care setting, 535
- Skokal, 2000, IV push at home?, RN, 63, 26
- Tice, 2002, Adverse effects with intravenous antibiotics with OPAT
- Rehm, 2000, Rates of adverse events associated with community-based parenteral anti-infective therapy, J Clin Outcomes Manage, 7, 23
- Martinelli, 1988, Aminoglycoside questionnaire results
- Hautekeete, 1995, Hepatotoxicity of antibitoics, Acta Gastroenterol Belg, 58, 290
- 1999, 2000–2001 Comprehensive accreditation manual for ambulatory care
- Barrell, 1998, ORYX: outcomes measurement and accreditation, Infusion, May, 37
- Poole, 1998, Outcomes measurements: making sense of the data, Infusion, May, 25
- Tice, 2000, Documenting the value of OPAT: outcomes studies and patient registries, Can J Infect Dis, 10, 45
- Tice, 2000, Outcomes registry for outpatient IV antimicrobial therapy, Infusion, May, 27
- Outpatient Parenteral Antimicrobial Therpay Outcomes Registry Web site
- Tice, 2003, Reasons for failures with OPAT [abstract 293]
- Arditi, 1990, Convalescent outpatient therapy for selected children with acute bacterial meningitis, Semin Pediatr Infect Dis, 1, 404
- Sudela, 1990, Nursing aspects of pediatric home infusion therapy for the treatment of serious, Semin Pediatr Infect Dis, 1, 306
- Tice, 2003, OPAT outcomes registry evaluaton of diabetic extremity infections [abstract 291]
- Wai, 1999, A cost analysis of an outpatient parenteral antibiotic program (OPAT): a Canadian teaching hospital and ministry of health perspective, 133
- Tice, 1997, Osteomyelitis
- Rehm, 1992, Home intravenous antibiotic therapy (HIVAT) for endocarditis
- Gentry, 1989, New approches to the diagnosis and treatment of infective endocarditis, Texas Heart Institute J, 16, 250
Cited by
Items 401–500 of 575
Ghazanfar, A., Harrison, J., Hossain, M., & Morsy, M. (2015) · Saudi Journal of Kidney Diseases and Transplantation · doi:10.4103/1319-2442.168560 · Cited by 5
Outpatient Parenteral Antimicrobial Therapy: A Long‐Overdue Option for Older Adults
High, K. P. (2007) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01141.x · Cited by 5
Editorial Commentary : Fortune Favors the Bold: Give a Beta-Lactam!
Blumenthal, K. G., & Shenoy, E. S. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw467 · Cited by 5
Kumar, A., Panda, P. K., Kant, R., Bairwa, M., Pai, V. S., Singh, D., & Das, N. (2025) · World Journal of Methodology · doi:10.5662/wjm.v15.i4.102894 · Cited by 4
Manders, I. G., Comello, D., Souverein, D., Euser, S. M., Herpers, B. L., Vetten, J., Kalpoe, J., Goeijenbier, M., & van Lelyveld, S. F. L. (2025) · Antibiotics · doi:10.3390/antibiotics14111103 · Cited by 4
Sabina, M., Cobian, J., & Dibo, I. (2024) · Cureus · doi:10.7759/cureus.54078 · Cited by 4
Hase, R., Uno, S., Miyoshi, K., FUJITA, K., Suzuki, H., SUZUKI, D., Mikawa, T., Muranaka, K., & Hosokawa, N. (2015) · Kansenshogaku zasshi · doi:10.11150/kansenshogakuzasshi.89.567 · Cited by 4
Dargan, S., Zvonar, R. K., & Saginur, R. (2007) · The Canadian Journal of Hospital Pharmacy · doi:10.4212/cjhp.v60i3.172 · Cited by 4
Pardos‐Gea, J., Maza, Ú., Pérez‐López, J., & San‐José, A. (2011) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2010.09.011 · Cited by 4
Continuous Infusion of Beta-lactam Antibiotics
Muller, A. E., & Mouton, J. W. (2013) · Springer eBooks · doi:10.1007/978-0-387-75613-4_10 · Cited by 4
Evaluation of dalbavancin on length of stay in acute bacterial skin and skin structure infections
Jones, B. M., Hersey, R., Taylor, C., & Bland, C. M. (2019) · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · doi:10.1002/jac5.1085 · Cited by 4
Assessment for Catheter Function, Dressing Adherence and Device Necessity
Weston, V. (2019) · Springer eBooks · doi:10.1007/978-3-030-03149-7_17 · Cited by 4
Houfi, A. E., Althaqafi, A., Alenazi, T. H., Farahat, F. M., Solem, C. T., Stephens, J., Johnson, C. W., Macahilig, C. P., Tang, W. Y., & Haider, S. (2020) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2020.03.018 · Cited by 4
Domiciliary parenteral antibiotic therapy: A prospective analysis of the last 12 years
Cantero, M. J. P., Rodríguez, A. M., Cardona, A. L. U., & Ortiz, A. J. (2014) · Anales de Pediatría (English Edition) · doi:10.1016/j.anpede.2013.05.001 · Cited by 4
Optimizing Delivery of Care for Patients with MRSA Infection: Focus on Transitions of Care
McKinnon, P. S., Boening, A. J., & Amin, A. (2011) · Hospital Practice · doi:10.3810/hp.2011.04.391 · Cited by 4
Daptomicina en el paciente con hospitalización a domicilio
Ramallo, V. J. G. (2010) · Medicina Clínica · doi:10.1016/s0025-7753(10)70040-3 · Cited by 4
Khoury, A., & Rattanasuwan, T. (2017) · The American Pharmacists Association eBooks · doi:10.21019/pharmacotherapyfirst.endocarditis_overview · Cited by 4
Melzer, M., Macpherson, L., & Welch, C. A. (2016) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2016-134441 · Cited by 4
Patients’ experiences of natalizumab treatment in a home environment: a qualitative study
Juaton, M., Cusack, L., & Schulz, T. (2020) · Australian journal of advanced nursing · doi:10.37464/2020.371.4 · Cited by 4
Principles of Anti-Infective Therapy
Bradley, J. S., & Long, S. S. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-2702-9.00291-9 · Cited by 4
Self-citationIntroduction to the Symposium on Antimicrobial Therapy
Temesgen, Z. (2011) · Mayo Clinic Proceedings · doi:10.4065/mcp.2011.0002 · Cited by 4
Editorial: Disease management by protocol — Rules of the game
Kumar, A. (2004) · The Indian Journal of Pediatrics · doi:10.1007/bf02730721 · Cited by 4
Aufiero, M. A., & Hohl, T. M. (2026) · mBio · doi:10.1128/mbio.03982-25 · Cited by 3
Improving the safety of outpatient parenteral antimicrobial therapy for patients with solid tumors
Robins, A., Dishner, E., McDaneld, P. M., Rowan, M., Bartek, J., Jiang, Y., Adachi, J. A., & Garnes, N. D. (2021) · Supportive Care in Cancer · doi:10.1007/s00520-021-06549-3 · Cited by 3
Missiaen, L., Vogelaers, D., Roo, P. J. D., Hoecke, F. V., Vanmierlo, B., Ravelingien, T., & Langbeen, J. (2023) · Acta Clinica Belgica · doi:10.1080/17843286.2023.2278237 · Cited by 3
An Analytical View on the Use of Flucloxacillin for Outpatient Parenteral Antimicrobial Therapy
Nguyen, T., Spriet, I., Quintens, C., Elst, L. V., Hà, P. T. T., Schepdael, A. V., & Adams, E. (2024) · Microorganisms · doi:10.3390/microorganisms12102039 · Cited by 3
Johnson, T. M., Webster, L. W., Mehta, M., Johnson, J. E., Cortes-Penfield, N. W., & Rivera, C. G. (2023) · Therapeutic Advances in Infectious Disease · doi:10.1177/20499361231193920 · Cited by 3
Pneumonia and Asthma – diagnosing and treatment in pediatric medicine
Rolek, A. (2024) · Emergency Medical Service · doi:10.36740/emems202403108 · Cited by 3
Cummins, S. A., Beeler, C., Muloma, E., & Erdman, S. M. (2020) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0000000000000933 · Cited by 3
SCOPUS analysis of publications on nursing and phlebitis
Alkan, S., & AKYÜZ, H. Ö. (2023) · Demiroglu Science University Florence Nightingale Journal of Medicine · doi:10.5606/fng.btd.2023.23 · Cited by 3
Antibioticoterapia parenteral domiciliaria
Sánchez, M. Á. G., & Orbáiz, C. G. (2006) · Seminarios de la Fundación Española de Reumatología · doi:10.1016/s1577-3566(06)75097-7 · Cited by 3
Outpatient Parenteral Antimicrobial Therapy
Bowling, J. E., Lewis, J. S., & Owens, A. D. (2012) · Hospital Medicine Clinics · doi:10.1016/j.ehmc.2012.07.002 · Cited by 3
Houfi, A. E., Javed, N., Nathwani, D., Solem, C. T., Macahilig, C. P., Stephens, J., Raghubir, N., Hájek, P., Li, J. Z., & Haider, S. (2014) · Value in Health · doi:10.1016/j.jval.2014.08.2549 · Cited by 3
Hoen, B., Tornos, P., Antunes, M. J., Lekakis, J. P., Lengyel, M., Naber, C. K., & Zamorano, J. L. (2009) · Cited by 3
Gewitz, M. H., & Taubert, K. A. (2012) · Wiley eBooks · doi:10.1002/9781444398786.ch60 · Cited by 3
Reesi, M. A., N/A, Al-Maani, A. S., Paul, G. O., & Al-Arimi, S. (2014) · Sultan Qaboos University medical journal · doi:10.18295/2075-0528.1634 · Cited by 3
Treatment Options for Gram-Positive and Gram-Negative Bacteria: Focus on Ceftriaxone
Hirai, Y. (2011) · Clinical Medicine Reviews in Therapeutics · doi:10.4137/cmrt.s1612 · Cited by 3
Pallasch, J., Takahashi, M., Taubert, K. A., Shulman, S. T., Burns, J. C., Falace, D. A., Newburger, J. W., Gewitz, H.-S., Tong, D., Steckelberg, J. M., et al. (2007) · Cited by 3
Prestwood, J., Chang, D., McGann, P., & Barsoumian, A. E. (2018) · Military Medicine · doi:10.1093/milmed/usy241 · Cited by 3
Habib, G., Hoen, B., Tornos, P., Thuny, F., Prendergast, B., Vilacosta, I., Moreillon, P., Antunes, M. J., Thilén, U. J., Lekakis, J. P., et al. (2009) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(09)73540-6 · Cited by 3
Debaenst, N., Seyler, L., Putman, K. D., Borre, I. V. D., & Vanlauwe, J. (2020) · Acta Clinica Belgica · doi:10.1080/17843286.2020.1772572 · Cited by 3
Schauberger, A., Klug, A., Hagebusch, P., Kemmerer, M., Hoffmann, R. F. G., & Gramlich, Y. (2020) · The Journal of Arthroplasty · doi:10.1016/j.arth.2020.06.006 · Cited by 3
Howe, Z., & McCann, J. (2018) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy210.1597 · Cited by 3
Konold, V., Weissman, S. J., Kronman, M. P., Brothers, A. W., Pak, D., Felder, K. K., & Vaz, L. E. (2023) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2023.36 · Cited by 2
Jones, H. (2012) · Advances in Skin & Wound Care · doi:10.1097/01.asw.0000412918.04324.77 · Cited by 2
Comparison of Patient Outcomes in a Pharmacist-Led Parenteral Antimicrobial Therapy Program
Howe, Z., Saum, L. M., & McCann, J. (2020) · Digital Commons @ Butler University (Butler University) · Cited by 2
Pineo, T., Goldman, J. D., Swartzentruber, G. S., Kanderi, T., QURASHI, H. M. S., & Dimech, C. T. (2021) · Drug and Alcohol Dependence Reports · doi:10.1016/j.dadr.2021.100020 · Cited by 2
Marx, A. H., Cluck, D. B., Green, S. B., Anderson, D. T., Stover, K. R., Chastain, D. B., Covington, E. W., Jones, B. M., Lantz, E., Rausch, E. P., et al. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac600 · Cited by 2
Hjemmebehandling med intravenøs antibiotika
Jacobsen, M., Helleren, R., Gallefoss, F., & Opsal, A. (2023) · Nordisk tidsskrift for helseforskning · doi:10.7557/14.6742 · Cited by 2
Tratamiento antibiótico parenteral domiciliario de la bacteriemia por Staphylococcus aureus
Sopena, N., Benitez, R., Molinos, S., & Cuxart, A. (2011) · Medicina Clínica · doi:10.1016/j.medcli.2011.03.005 · Cited by 2
Ceftaroline-Induced Agranulocytosis
Sahar, N., Ratajczak, T., & Conger, N. G. (2016) · Journal of Medical Cases · doi:10.14740/jmc2489w · Cited by 2
Osteomyelitis and Other Bone and Joint Infections
Helou, O. C. E., Berbari, E. F., & Osmon, D. R. (2009) · Wiley eBooks · doi:10.1002/9781444308464.ch22 · Cited by 2
Implant‐Associated Vertebral Osteomyelitis
Kowalski, T. J. (2015) · Wiley eBooks · doi:10.1002/9781118581742.ch21 · Cited by 2
Analytic Reviews: Management of Aminoglycosides in the Intensive Care Unit
Radigan, E., Gilchrist, N. A., & Miller, M. A. (2010) · Cited by 2
Principles of Anti-Infective Therapy
Bradley, J. S., & Long, S. S. (2008) · Elsevier eBooks · doi:10.1016/b978-0-7020-3468-8.50295-9 · Cited by 2
Self-citationFarahmand, P., Kim, J., Twark, C., & Suzuki, J. (2019) · Psychosomatics · doi:10.1016/j.psym.2019.08.001 · Cited by 2
Irvine, J. W. D., Chapman, A. L. N., Lopez, C. V., Reid, K., Spittal, M., McCormick, S., & Dundas, S. (2019) · Clinical Infection in Practice · doi:10.1016/j.clinpr.2019.100002 · Cited by 2
Inpatient opioid use disorder treatment for the infectious disease physician
Seval, N., Eaton, E., & Springer, S. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-68328-9.00010-2 · Cited by 2
Staples, J. A., Ho, M., Ferris, D., Liu, G., Brubacher, J. R., Khan, M., Daly‐Grafstein, D., Tran, K. C., & Sutherland, J. M. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad082 · Cited by 2
Farmacovigilância na prática clínica : impacto sobre reações adversas e custos hospitalares
Mahmud, S. D. P. (2006) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 2
Cunha, B. A. (2009) · Journal of Chemotherapy · doi:10.1179/joc.2009.21.2.199 · Cited by 2
Guerrero, M. P. (2016) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 2
Touat, M. B. (2020) · theses.fr (ABES) · doi:10.70675/3b7fa1e8zd038z469cza345z4a6f15b405a1 · Cited by 2
Optimizing the Use of Antimicrobial Agents
Simon, M. S., & Calfee, D. P. (2016) · Elsevier eBooks · doi:10.1016/b978-0-7020-6285-8.00139-8 · Cited by 1
Outpatient Parenteral Antimicrobial Therapy
Tice, A. D. (2010) · Elsevier eBooks · doi:10.1016/b978-0-443-06839-3.00048-5 · Cited by 1
Self-citationBowhay, T. R., Tsang, T., Wei, J. C. Z., Edwik, W., Fridman, A., Hubber, J., Jo, J. Y., Mckay, N., O'Brien, C., Osmond‐Wallam, J., et al. (2023) · Internal Medicine Journal · doi:10.1111/imj.16173 · Cited by 1
A Service Model Guide to Outpatient Parenteral Antimicrobial Therapy (OPAT)
(2024) · British Journal of Nursing · doi:10.12968/bjon.2024.33.sup20.s1 · Cited by 1
Ross, J. K., Sieling, W. D., Billmeyer, K. N., Hirsch, E. B., Evans, M. D., Kline, S. E., & Galdys, A. L. (2025) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaf343 · Cited by 1
Ajapuje, P. S., Sameel, S. S., Gaikwad, D., Kumar, P. S., & Dharangutti, R. (2026) · BMC Research Notes · doi:10.1186/s13104-026-07637-5 · Cited by 1
Mohammed, S. A., Roberts, J. A., Nicolás, D., Aslan, A. T., Senok, A. C., Aldabal, L., Erku, D., Nor, A. N. M., Pollard, J., Cotta, M. O., et al. (2026) · PubMed Central · doi:10.1093/jacamr/dlag095 · Cited by 1
Hassanzai, M., Contrucci, R. R., Koch, B. C. P., Verkaik, N. J., de Winter, B. C. M., & van Onzenoort, H. A. W. (2026) · Antibiotics · doi:10.3390/antibiotics15060630 · Cited by 1
Huang, H.-P., Huang, P.-H., Huang, W.-H., Liu, C.-W., Tseng, C.-H., Wang, H.-W., Cheng, C.-H., Ho, C.-M., Liu, P., & Yeh, T.-K. (2026) · Antibiotics · doi:10.3390/antibiotics15070689 · Cited by 1
Analysis of Lung Parenchymal Sequelae Following Treatment for Lung Abscess
Lee, J.-Y., Koo, S., Park, K. A., Seo, Y., Kim, S. H., Kim, Y., Kim, K. U., Hwang, J. H., & Uh, S. (2011) · Tuberculosis & respiratory diseases · doi:10.4046/trd.2011.71.6.438 · Cited by 1
Daptomicina en el tratamiento antimicrobiano parenteral ambulatorio
Cervera, C., & Mestres, C. A. (2012) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(12)70074-5 · Cited by 1
Manejo de las enfermedades infecciosas en el medio extrahospitalario
Soriano, A. S., Lillo, J. A. A., Ballesteros, J., & Ramallo, V. J. G. (2010) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0304-5412(10)70032-9 · Cited by 1
Kelesidis, T. (2014) · Clinical Medicine Reviews in Therapeutics · doi:10.4137/cmrt.s9283 · Cited by 1
Veillette, J. J., Bittner, L., Skalweit, M. J., Stiefel, U., Burant, C. J., Hirsch, A., & Sims, S. (2016) · Journal of Pharmacy and Pharmacology · doi:10.17265/2328-2150/2016.06.001 · Cited by 1
Outpatient Parenteral Antimicrobial Therapy
Hsueh, K., & Greene, J. B. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00053-9 · Cited by 1
Valinetz, E. D., Beeler, C., & Erdman, S. M. (2020) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0000000000000972 · Cited by 1
Antibiotic Use in Home Health: A Primer
Bossaer, J. B., & Lewis, P. O. (2011) · Home Health Care Management & Practice · doi:10.1177/1084822311422561 · Cited by 1
Use of injectable drugs with oral-formulation alternatives for outpatients in South Korea
Ku, H., Park, S., Lee, S., Song, I., Park, H., Kim, T., Lee, J. I., & Lee, E. (2014) · Archives of Pharmacal Research · doi:10.1007/s12272-014-0488-0 · Cited by 1
A STUDY PROFILE OF LUNG ABSCESS PATIENT COMING TO TERTIARY CARE CENTER AHMEDABAD
Gupta, A., & Dutt, N. (2015) · National Journal of Medical Research · Cited by 1
Poretz, D. M., & Rehm, S. J. (2011) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0b013e31821e260a · Cited by 1
Self-citationMiguel Antonio Sánchez, C. (2015) · Revista Colombiana de Enfermería · doi:10.18270/rce.v9i9.562 · Cited by 1
Pathogen-directed antibiotic therapy
Reubsaet, L. L., & Ekkelenkamp, M. B. (2016) · Elsevier eBooks · doi:10.1016/b978-0-08-100205-6.00011-2 · Cited by 1
Thiele, H. (2016) · Journal of Pharmacy Practice and Research · doi:10.1002/jppr.1304 · Cited by 1
Keats, K. R. (2019) · UKnowledge (University of Kentucky) · Cited by 1
Compassionate Care of the Patient Who Uses Substances: Implications for the Infusion Nurse
Knapp, M., & Gilles, S. (2020) · Journal of Infusion Nursing · doi:10.1097/nan.0000000000000359 · Cited by 1
Principles of Anti-Infective Therapy
Bradley, J. S., & Long, S. S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-40181-4.00289-9 · Cited by 1
Self-citationInfective Endocarditis and Device Infections
Klassen, S. L., Lemieux, J. E., Barshak, M. B., & Dal‐Bianco, J. P. (2020) · Springer eBooks · doi:10.1007/978-3-030-45792-1_22 · Cited by 1
Coursen, J. C., Roth, P., Schrank, C., & Schrank, J. (2020) · International Journal of Infectious Diseases and Therapy · doi:10.11648/j.ijidt.20200504.12 · Cited by 1
Gil-Navarro, M. V., Márquez, R. L., Gutiérrez, N. B., Álvarez‐Marín, R., Navarro-Amuedo, M. D., Praena‐Segovia, J., Carmona-Caballero, J. M., Fraile-Ramos, E., & López-Cortés, L. E. (2020) · Enfermedades infecciosas y microbiologia clinica (English ed ) · doi:10.1016/j.eimce.2020.01.016 · Cited by 1
Török, M. E., Cooke, F. J., & Moran, E. (2016) · Oxford University Press eBooks · doi:10.1093/med/9780199671328.003.0001 · Cited by 1
Bradley, J. S., & Sauberan, J. B. (2008) · Elsevier eBooks · doi:10.1016/b978-0-7020-3468-8.50298-4 · Cited by 1
Self-citationPuntos farmacéuticos clave de la terapia antimicrobiana parenteral domiciliaria: revisión narrativa
Saco, J. S., Vilariño, G. R., Apiñaniz, R. A., & Gomez, M. F. H. (2023) · Hospital a Domicilio · doi:10.22585/hospdomic.v7i1.181 · Cited by 1
DENARDIN, I. C., ALVES, T. B., Cunha, M., & Silva, J. D. C. (2023) · Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde · doi:10.30968/rbfhss.2023.144.0975 · Cited by 1
Sofie, S., Langbeen, J., Blot, S. I., Wim, T., Debrauwere, M., & Vogelaers, D. (2024) · The Journal of Vascular Access · doi:10.1177/11297298241305731 · Cited by 1
Venter, S., & Aldiabat, K. M. (2025) · Journal of Holistic Nursing Science · doi:10.31603/nursing.v12i1.12499 · Cited by 1
Diagnosis and Management of Infective Endocarditis
Camitta, M. G. W., Geme, J. W. S., & Li, J. S. (2013) · Springer eBooks · doi:10.1007/978-1-4471-4619-3_4 · Cited by 1
Electronic Resources to Support Evidence-Based Practice in the Home Health Care Setting
Wardell, T. L. (2005) · Home Health Care Management & Practice · doi:10.1177/1084822304273381 · Cited by 1
Metadata
- Authors
- Tice, A. D., Rehm, S. J., Dalovisio, J. R., Bradley, J. S., Martinelli, L. P., Graham, D. R., Gainer, R. B., Kunkel, M. J., Yancey, R. W., & Williams, D. N.
- Affiliations
- University of Hawaiʻi at Mānoa (US)
- Cleveland Clinic (US)
- Ochsner Medical Center (US)
- Rady Children's Hospital-San Diego (US)
- Consultants in Infectious Diseases, Lubbock, Texas
- Springfield Clinic (US)
- Morgantown Internal Medicine Group, Morgantown, West Virginia
- Pfizer (United States) (US)
- Florida Infection Physicians, Gainsville
- Hennepin County Medical Center (US)
- Corresponding author
- Tice, Alan D.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-06-15
- Volume
- 38
- Issue
- 12
- Pages
- 1651-1671
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2141994303
- Cited by
- 532
- References
- 239
- Citations by year
- 2026: 7 · 2025: 13 · 2024: 18 · 2023: 17 · 2022: 21 · 2021: 21 · 2020: 31 · 2019: 38 · 2018: 48 · 2017: 40 · 2016: 43 · 2015: 32 · 2014: 36 · 2013: 31 · 2012: 21
- FWCI
- 9.51
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Bristol-Myers Squibb
- Pfizer
- AstraZeneca
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
- Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections
- Keywords
- outpatient parenteral antimicrobial therapy, outpatient antibiotic therapy, patient selection, antimicrobial selection, once-daily dosing, drug stability, laboratory monitoring, adverse drug reactions, quality of care, multidisciplinary team
- MeSH terms
- Adult, Anti-Bacterial Agents, Child, Home Care Services, Humans, Infusions, Intravenous, Outpatients, Patient Care Team, Pediatrics, Drug Monitoring, Outcome Assessment, Health Care, Patient Selection, Home Infusion Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.